Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

0.6801
Delayed Data
As of 3:59pm ET
 +0.0099 / +1.48%
Today’s Change
0.61
Today|||52-Week Range
4.90
-67.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$25.0M

Company Description

Trovagene, Inc. is a molecular diagnostic company, which focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology for use in disease detection and monitoring across a variety of medical disciplines. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.

Contact Information

TrovaGene, Inc.
11055 Flintkote Avenue
San Diego California 92121
P:(858) 952-7570
Investor Relations:

Employees

Shareholders

Mutual fund holders2.66%
Other institutional17.88%
Individual stakeholders15.18%

Top Executives

Bill WelchPresident, Chief Executive Officer & Director
Mark ErlanderChief Scientific Officer
Karsten SchmidtChief Technology Officer
Elizabeth AndersonVice President-Finance & Administration
Nick NelsonVice President-Strategy & Corporate Development